Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$34.21K
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
0.84%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$483.6K
Q3 2024
Cash
Q3 2024
P/E
0.000
EST
Free Cash Flow

Revenues

Revenues

Revenue YoY Change

No data

Revenues

Concept 2023 2022
Revenue
YoY Change

Expenses

Cost Of Revenues

No data

Gross Profit

No data

Gross Profit Margin

No data

Gross Profit

Concept 2023 2022
Revenue
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

No data

Research & Development

No data

Depreciation, Depletion & Amortization

No data

SGA Expense to Gross Profit Ratio

No data

R&D To Gross Profit Ratio

No data

DDA To Gross Profit Ratio

No data

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2023 2022
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $14.90K $21.01K
YoY Change -29.09% 14.58%
Operating Profit -$14.90K -$21.01K
YoY Change -29.09% 14.58%

Interest Expenses

Interest Expenses To Operating Income %

No data

Other Expense/Income

Interest & Other Expense/Income

Concept 2023 2022
Interest Expense $10.42K $9.730K
YoY Change 7.11% 32.83%
% of Operating Profit
Other Income/Expense, Net -$22.90K -$21.46K
YoY Change 6.69% 16.26%

Income/Loss

Pretax Income

Income Tax

No data

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

No data

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

No data

Pretax & Net Income

Concept 2023 2022
Pretax Income -$37.79K -$42.47K
YoY Change -11.01% 15.42%
Income Tax
% Of Pretax Income
Net Earnings -$37.79K -$42.47K
YoY Change -11.01% 15.42%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.01
Diluted Earnings Per Share

Assets & Liabilities

Cash & Short-Term Investments

No data

Cash & Equivalents

Cash To Operating Expenses Ratio

No data

Inventory

No data

Receivables

No data

Total Short-Term Assets

Property, Plant And Equipment

No data

Long-Term Investments

No data

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

No data

Long Term Debt Due

No data

Total Short-Term Liabilities

Long-Term Debt

No data

Other Long-Term Liabilities

No data

Total Long-Term Liabilities

No data

Total Liabilities

Short-Term To Long-Term Debt Ratio

No data

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

No data

Assets & Liabilities

Concept 2023 2022
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
Total Assets
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
Total Liabilities
YoY Change

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

No data

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2023 2022
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

No data

Book Value

Free Cash Flow

No data

Free Cash Flow YoY

No data

Free Cash Flow Margin

No data

Dividends

Dividends

No data

Stock Price

No data
Market Cap: $0.00

About CANCER CAPITAL CORP

Cancer Capital Corp. engages in the development of alternative medical waste treatment and processing equipment system. The company is headquartered in Salt Lake City, Utah. The company went IPO on 2011-09-14. The firm was formed to develop an alternative medical waste treatment and processing equipment system. The firm intends to seek, investigate, and, if warranted, acquire an interest in a business opportunity. The firm's acquisition of a business opportunity may be made by merger, exchange of stock, or otherwise. The firm has no operating business. The firm has not generated any revenues.

Industry: Blank Checks Peers: